FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2275889916> ?p ?o ?g. }

• W2275889916 endingPage "862" @default.
• W2275889916 startingPage "857" @default.
• W2275889916 abstract "PURPOSE The purpose is twofold: (1) to identify the malignant glioma patients treated in a trial of hyperfractionated radiotherapy (RT) and carmustine (BCNU) who may have been eligible for a stereotactic radiosurgery (SRS) boost; and (2) to compare survival of such patients with that of those considered SRS-ineligible. PATIENTS AND METHODS From January 1983 to July 1989, 778 malignant glioma patients were enrolled on Radiation Therapy Oncology Group (RTOG) 83-02, a randomized phase I/II hyperfractionated RT dose-escalation trial with BCNU chemotherapy. The SRS criteria used in a single-institution trial were applied to these patients; they are: Karnofsky performance status (KPS) of greater than 60; well-circumscribed tumor less than 4.0 cm; no subependymal spread; and a location not adjacent to brainstem or optic chiasm. RESULTS Eighty-nine patients (11.9%) were identified as potentially SRS-eligible. The median survival times (MST) and 18-month survival rates of the 89 eligible and 643 ineligible patients were 14.4 versus 11.7 months and 40% versus 27%, respectively (P = .047). The MST and 18-month survival rate of the 544 SRS-ineligible patients with KPS greater than 60 were 12.1 months and 29%, respectively, and were not statistically inferior to the survival of the SRS-eligible group (P = .21). Multivariate analysis revealed age, KPS, and histopathology to be strongly predictive of survival, and SRS eligibility was also significantly predictive (P = .047). CONCLUSION SRS-eligible patients enrolled on RTOG 83-02 had survival superior to that of the SRS-ineligible group, and this advantage is mainly due to the selection of a subgroup with a high minimum KPS." @default.
• W2275889916 created "2016-06-24" @default.
• W2275889916 creator A5006394078 @default.
• W2275889916 creator A5026088869 @default.
• W2275889916 creator A5030653008 @default.
• W2275889916 creator A5035978215 @default.
• W2275889916 creator A5036811863 @default.
• W2275889916 creator A5050163548 @default.
• W2275889916 creator A5060857674 @default.
• W2275889916 creator A5064031032 @default.
• W2275889916 creator A5073984522 @default.
• W2275889916 creator A5086843728 @default.
• W2275889916 date "1993-05-01" @default.
• W2275889916 modified "2023-09-27" @default.
• W2275889916 title "Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02." @default.
• W2275889916 cites W1580788756 @default.
• W2275889916 cites W1759766614 @default.
• W2275889916 cites W1790847442 @default.
• W2275889916 cites W1964421702 @default.
• W2275889916 cites W1967734901 @default.
• W2275889916 cites W1973202369 @default.
• W2275889916 cites W1979300931 @default.
• W2275889916 cites W2002119598 @default.
• W2275889916 cites W2029445057 @default.
• W2275889916 cites W2031230850 @default.
• W2275889916 cites W2033128037 @default.
• W2275889916 cites W2036560693 @default.
• W2275889916 cites W2038613393 @default.
• W2275889916 cites W2041182824 @default.
• W2275889916 cites W2047447875 @default.
• W2275889916 cites W2054990897 @default.
• W2275889916 cites W2057966391 @default.
• W2275889916 cites W2069835258 @default.
• W2275889916 cites W2077668530 @default.
• W2275889916 cites W2085340609 @default.
• W2275889916 cites W2117322456 @default.
• W2275889916 cites W2167712950 @default.
• W2275889916 cites W2168934883 @default.
• W2275889916 cites W2279957693 @default.
• W2275889916 cites W2497404581 @default.
• W2275889916 doi "https://doi.org/10.1200/jco.1993.11.5.857" @default.
• W2275889916 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8487050" @default.
• W2275889916 hasPublicationYear "1993" @default.
• W2275889916 type Work @default.
• W2275889916 sameAs 2275889916 @default.
• W2275889916 citedByCount "107" @default.
• W2275889916 countsByYear W22758899162013 @default.
• W2275889916 countsByYear W22758899162015 @default.
• W2275889916 countsByYear W22758899162018 @default.
• W2275889916 countsByYear W22758899162019 @default.
• W2275889916 countsByYear W22758899162020 @default.
• W2275889916 countsByYear W22758899162022 @default.
• W2275889916 crossrefType "journal-article" @default.
• W2275889916 hasAuthorship W2275889916A5006394078 @default.
• W2275889916 hasAuthorship W2275889916A5026088869 @default.
• W2275889916 hasAuthorship W2275889916A5030653008 @default.
• W2275889916 hasAuthorship W2275889916A5035978215 @default.
• W2275889916 hasAuthorship W2275889916A5036811863 @default.
• W2275889916 hasAuthorship W2275889916A5050163548 @default.
• W2275889916 hasAuthorship W2275889916A5060857674 @default.
• W2275889916 hasAuthorship W2275889916A5064031032 @default.
• W2275889916 hasAuthorship W2275889916A5073984522 @default.
• W2275889916 hasAuthorship W2275889916A5086843728 @default.
• W2275889916 hasConcept C126322002 @default.
• W2275889916 hasConcept C141071460 @default.
• W2275889916 hasConcept C143998085 @default.
• W2275889916 hasConcept C2776694085 @default.
• W2275889916 hasConcept C2778119113 @default.
• W2275889916 hasConcept C2778227246 @default.
• W2275889916 hasConcept C2780147359 @default.
• W2275889916 hasConcept C2780387249 @default.
• W2275889916 hasConcept C502942594 @default.
• W2275889916 hasConcept C509974204 @default.
• W2275889916 hasConcept C71924100 @default.
• W2275889916 hasConceptScore W2275889916C126322002 @default.
• W2275889916 hasConceptScore W2275889916C141071460 @default.
• W2275889916 hasConceptScore W2275889916C143998085 @default.
• W2275889916 hasConceptScore W2275889916C2776694085 @default.
• W2275889916 hasConceptScore W2275889916C2778119113 @default.
• W2275889916 hasConceptScore W2275889916C2778227246 @default.
• W2275889916 hasConceptScore W2275889916C2780147359 @default.
• W2275889916 hasConceptScore W2275889916C2780387249 @default.
• W2275889916 hasConceptScore W2275889916C502942594 @default.
• W2275889916 hasConceptScore W2275889916C509974204 @default.
• W2275889916 hasConceptScore W2275889916C71924100 @default.
• W2275889916 hasIssue "5" @default.
• W2275889916 hasLocation W22758899161 @default.
• W2275889916 hasLocation W22758899162 @default.
• W2275889916 hasOpenAccess W2275889916 @default.
• W2275889916 hasPrimaryLocation W22758899161 @default.
• W2275889916 hasRelatedWork W1991895134 @default.
• W2275889916 hasRelatedWork W2003938723 @default.
• W2275889916 hasRelatedWork W2025724318 @default.
• W2275889916 hasRelatedWork W2047967234 @default.
• W2275889916 hasRelatedWork W2079427446 @default.
• W2275889916 hasRelatedWork W2118496982 @default.
• W2275889916 hasRelatedWork W2149452554 @default.
• W2275889916 hasRelatedWork W2347438058 @default.

• next